Free Newsletter
FDA blog aims to chronicle transparency push
Free newsletter via e-mail
Tools
FDA said it wanted to be more "transparent," more "open" about its decision-making. Already, the agency has launched a blog to detail its quest for transparency--and solicit input from the public. Enter your comments at will, but remember: no vulgar language allowed. Release
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: